CJC-1295 is a synthetic GHRH (growth hormone releasing hormone) analogue made up of 30 amino acids. It has been found in research to be highly effective with regards to the increase of growth hormone secretion and IGF-1 without negatively affecting the pulsatility of GH secretion.
In research CJC-1295 is often combined with Ipamorelin due to its enhanced specificity as a GHRH. This peptide generates similar increases in growth hormone secretion, but without the appetite stimulation and increase in cortisol, acetylcholine, prolactin, and aldosterone seen with other peptides in its class. In research this peptide has been found to be very well-tolerated and perfect when combined with Ipamorelin.
Research has shown the following potential benefits of CJC-1295:
iPharmix CJC-1295 DAC has a peptide purity level that exceeds 99.0% as determined by HPLC. This peptide was synthesized with no additives and is supplied as a white lyophilized (freeze-dried) powder.
It is recommended to reconstitute the lyophilized CJC-1295 DAC in bacteriostatic water, which can then be further diluted in other aqueous solutions. Lyophilized CJC-1295 DAC although stable at room temperature for 90 days, should be stored between 2-8°C. Upon reconstitution, CJC-1295 DAC should be stored between 2-8°C out of direct light for up to 14 days. For future use store below -18°C. Prevent repeated freeze-thaw cycles.
THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. This product is not a drug and has not been approved by the FDA to prevent or cure any medical condition or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals.
Source: PubChem
Peptide Sequence: Aib-His-D-2Nal-D-Phe-Lys
Molecular Formula: C165H269N47O46
Molecular Weight: 3647.2 g/mol
PubChem CID: 91971820
CAS Number: 446262-90-4